Picture loading failed.

Pre-Made Suvratoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Suvratoxumab (INN; development code MEDI4893) is a human monoclonal antibody designed for the prevention of nosocomial pneumonia caused by Staphylococcus aureus.

Order information

Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-539-1mg 1mg 3090
GMP-Bios-ab-539-10mg 10mg 21890
GMP-Bios-ab-539-100mg 100mg 148000
GMP-Bios-ab-539-xmg >100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Pre-Made Suvratoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody
INN Name Suvratoxumab
TargetToxin A
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusActive
100% SI Structure4u6v:HL:KM
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2016
Year Recommended2017
CompaniesBiosynexus;GlaxoSmithKline;Regeneron Pharmaceuticals;MedImmune
Conditions Approvedna
Conditions ActiveNosocomial pneumonia
Conditions Discontinuedna
Development Techna